ADPKD Cure Guide Is there a cure for ADPKD?
Short answer: no proven human cure yet. That does not mean cure research is fake, it means the current cure-focused work is still early,
preclinical, or in very limited early clinical phases.
What is true right now
- No therapy is clinically proven to cure ADPKD in humans.
- Gene therapy and gene editing are real research lanes, but they are not current standard care.
- Better human models and organoids are useful, but they are not efficacy proof.
What is worth watching
- Gene editing/therapy correction of causal variants (PKD1/PKD2), **Early clinical signal:** VX-407 Phase 2a (AGLOW) actively recruiting for PKD1-subset variants; started Nov 2025, primary completion ~July 2027. FDA-regulated gene-therapy approach.
- RNA-targeted correction/silencing strategies, **Status:** Preclinical. microRNA-mediated PKD1/PKD2 suppression as target (mechanistic pathway identified; no clinical trials yet).
- Cell/organ regenerative replacement concepts, **Status:** Exploratory preclinical; no active clinical pipelines identified.
- Multi-pathway disease interception (beyond single-target), **Status:** Emerging. Patient-derived adult renal organoids now support human-model screening of cyst biology across genotypes and nominate **Rho/planar-cell-polarity pathway inhibition** as a candidate cyst-reducing strategy (PMID41946363), but this remains preclinical.
What to ignore
- Anything marketed like a current ADPKD cure
- Preclinical results framed like patient-ready treatment
- Trial registry updates treated like proof of success